Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 1.000 | |
3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.545 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.529 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.529 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.525 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.521 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.518 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.517 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.517 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.515 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.512 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.512 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.510 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.510 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.508 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.505 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.504 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.503 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.503 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.502 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.501 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.500 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.499 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.498 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.498 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.497 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.497 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.497 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.496 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.496 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.495 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.494 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.493 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.492 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.492 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.492 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.491 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.491 | |
1dkf | BMS | Retinoic acid receptor alpha | / | 0.490 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.490 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.490 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.490 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.490 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.489 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.489 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.488 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.488 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.487 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.486 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.486 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.486 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.485 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.485 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.485 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.485 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.484 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.484 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.484 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.483 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.482 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.482 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.482 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.481 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.481 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.480 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
3ogq | AB1 | Pol polyprotein | / | 0.478 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.478 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.478 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.477 | |
2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.477 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.477 | |
3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.476 | |
4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.476 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.476 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.475 | |
3wxy | COA | Uncharacterized protein | / | 0.475 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.475 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.475 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.475 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.473 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.473 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.473 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.473 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.472 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.472 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.472 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.472 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.472 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.472 | |
4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.472 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.472 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.471 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.471 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.471 | |
3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.471 | |
3tea | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.471 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.471 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.470 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.470 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.470 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.470 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.470 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.469 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.469 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.469 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.469 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.468 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.468 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.468 | |
4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.468 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.467 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.467 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.467 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.466 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.466 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.465 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.465 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.465 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.465 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.465 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
1fp2 | HMO | Isoflavone-7-O-methyltransferase 8 | 2.1.1.150 | 0.464 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.464 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.464 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.464 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.464 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.464 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.464 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.464 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.464 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.463 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.463 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.463 | |
3ict | ADP | Coenzyme A disulfide reductase | / | 0.463 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.463 | |
4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.463 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.463 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.462 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.462 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.462 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.462 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.462 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.462 | |
4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.462 | |
2eq9 | FAD | Dihydrolipoyl dehydrogenase | / | 0.461 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2vxo | XMP | GMP synthase [glutamine-hydrolyzing] | 6.3.5.2 | 0.461 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.461 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.461 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.461 | |
4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.461 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.461 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.460 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.460 | |
1w2x | RCP | Acetyl-CoA carboxylase | / | 0.460 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.460 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
3h18 | PMS | Esterase/lipase | / | 0.460 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.460 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.460 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.459 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.459 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.459 | |
4dqu | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.459 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.459 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.459 | |
1rj6 | AZM | Carbonic anhydrase 14 | 4.2.1.1 | 0.458 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.458 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.458 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.458 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.458 | |
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.458 | |
3ntg | D72 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.458 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.458 | |
3wy0 | COA | Uncharacterized protein | / | 0.458 | |
3zuy | TCH | Transporter | / | 0.458 | |
4em9 | TCE | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.458 | |
4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.458 | |
4i3w | NAD | Aldehyde dehydrogenase (NAD+) | / | 0.458 | |
5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.458 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.457 | |
2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.457 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.457 | |
2yyl | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.457 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.457 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
4wbo | ANW | Rhodopsin kinase | / | 0.457 | |
4xwt | U5P | Ribonuclease J | / | 0.457 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.456 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.456 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.456 | |
3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.456 | |
3okx | SAM | S-adenosyl-L-methionine-binding protein RPA0152 | / | 0.456 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.456 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.456 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.456 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.456 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.455 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.455 | |
3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.455 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.455 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
4pl3 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.455 | |
4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.455 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.454 | |
1zy8 | FAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.454 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.454 | |
2wed | PP6 | Penicillopepsin-1 | 3.4.23.20 | 0.454 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.454 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
3w0o | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.454 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.454 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
4hnc | 0UT | Mandelate racemase | / | 0.454 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.454 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
4xgx | ADP | FAD:protein FMN transferase | / | 0.454 | |
4ydu | ADP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.454 | |
5cms | APR | O-acetyl-ADP-ribose deacetylase | / | 0.454 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.453 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
3cgc | FAD | Coenzyme A disulfide reductase | / | 0.453 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.453 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.453 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.453 | |
3ics | ADP | Coenzyme A disulfide reductase | / | 0.453 | |
3iqz | H4M | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.453 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.453 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.453 | |
1q4t | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.452 | |
1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.452 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.452 | |
2aqh | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.452 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.452 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.452 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
3q5i | ANP | Protein kinase, putative | / | 0.452 | |
3r35 | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.452 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.452 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.452 | |
4geb | 0LD | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.452 | |
1chw | HXC | Chalcone synthase 2 | 2.3.1.74 | 0.451 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.451 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.451 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.451 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.451 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
3bfa | 9OD | Odorant binding protein ASP1 | / | 0.451 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3r34 | COA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.451 | |
3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.451 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.451 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.451 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.451 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
1v9a | SAH | Uncharacterized protein | / | 0.450 | |
2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.450 | |
3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.450 | |
3r32 | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.450 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.450 | |
3vth | APC | Carbamoyltransferase | / | 0.450 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.450 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.450 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.449 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.449 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.449 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.449 | |
3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.449 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.449 | |
3nwy | GTP | Uridylate kinase | / | 0.449 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.449 | |
3zux | TCH | Transporter | / | 0.449 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.449 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.449 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.449 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
4zca | ADP | Kinesin-like protein KIF11 | / | 0.449 | |
5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1ol6 | ATP | Aurora kinase A | 2.7.11.1 | 0.448 | |
1pag | FMP | Antiviral protein I | 3.2.2.22 | 0.448 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.448 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.448 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.448 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
3il1 | B5D | Glutamate receptor 2 | / | 0.448 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.448 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.448 | |
4gst | GTD | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.448 | |
4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.448 | |
4iql | FMN | Enoyl-(Acyl-carrier-protein) reductase II | / | 0.448 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.448 | |
1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.447 | |
1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
1guf | NDP | Enoyl-[acyl-carrier-protein] reductase 1, mitochondrial | 1.3.1.10 | 0.447 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.447 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1pp9 | SMA | Cytochrome b | / | 0.447 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
3cp9 | C19 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
3csd | EMO | Putative ketoacyl reductase | 1.3.1 | 0.447 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.447 | |
3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.447 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.447 | |
4dta | ADN | APH(2'')-Id | / | 0.447 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.447 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.447 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.447 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
1dyj | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1fpq | SAM | Isoliquiritigenin 2'-O-methyltransferase | / | 0.446 | |
1ie4 | T44 | Transthyretin | / | 0.446 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.446 | |
2ic5 | GDP | Ras-related C3 botulinum toxin substrate 3 | / | 0.446 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.446 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.446 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.446 | |
4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.446 | |
4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
4lsm | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.446 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.446 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
4z9r | NAD | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.446 | |
1iyz | NDP | Probable quinone oxidoreductase | / | 0.445 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.445 | |
1ojt | FAD | Dihydrolipoyl dehydrogenase | / | 0.445 | |
1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.445 | |
2fto | CB3 | Thymidylate synthase | / | 0.445 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.445 | |
2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.445 | |
3qai | XNN | Ketohexokinase | / | 0.445 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
3sz0 | FAD | Sulfide-quinone reductase | / | 0.445 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.445 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
3vjh | J35 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.445 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.445 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
4nxw | ADP | Mitochondrial dynamics protein MID51 | / | 0.445 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.445 | |
5eow | FAD | 6-hydroxynicotinate 3-monooxygenase | 1.14.13.114 | 0.445 | |
5ii2 | LU2 | Protein polybromo-1 | / | 0.445 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.445 | |
1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
1e1k | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.444 | |
1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
1og5 | SWF | Cytochrome P450 2C9 | / | 0.444 | |
1ot7 | IU5 | Bile acid receptor | / | 0.444 | |
1q4u | 4CA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.444 | |
1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
1sn5 | T3 | Transthyretin | / | 0.444 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.444 | |
1uyr | D1L | Acetyl-CoA carboxylase | / | 0.444 | |
2ay3 | MPP | Aromatic-amino-acid aminotransferase | 2.6.1.57 | 0.444 | |
2idz | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
2pmd | GNP | Translation initiation factor 2 subunit gamma | / | 0.444 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3b7d | CNI | Glutamate receptor 2 | / | 0.444 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.444 | |
3inv | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.444 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.444 | |
3uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.444 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
4kgm | ATP | Uncharacterized protein | / | 0.444 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.444 | |
4ryv | ZEA | Protein LlR18A | / | 0.444 | |
4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.444 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.444 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.444 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1ict | T44 | Transthyretin | / | 0.443 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.443 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
3gco | VAL_TYR_GLN_PHE | Serine endoprotease DegS | 3.4.21.107 | 0.443 | |
3iw6 | PP0 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3opd | HIE | Heat shock protein 83 | / | 0.443 | |
3w0r | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.443 | |
4a28 | ADP | Kinesin-like protein KIF11 | / | 0.443 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.443 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
4kwi | 1TJ | Reductase homolog | / | 0.443 | |
5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.443 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.442 | |
2fsv | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.442 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.442 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
3bhl | THG | Thymidylate synthase | / | 0.442 | |
3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.442 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
3icr | FAD | Coenzyme A disulfide reductase | / | 0.442 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
3qly | 55V | Uncharacterized protein | / | 0.442 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
3zpu | M8B | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.442 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.442 | |
4bcr | WY1 | Peroxisome proliferator-activated receptor alpha | / | 0.442 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.442 | |
4jaq | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.442 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
4rrx | LUR | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.442 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.442 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.442 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1g67 | TZP | Thiamine-phosphate synthase | / | 0.441 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.441 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.441 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.441 | |
2oor | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.441 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.441 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.441 | |
3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.441 | |
3t5i | SER_SER_CMT_FAR | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.441 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.441 | |
3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.441 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
4nxu | ADP | Mitochondrial dynamics protein MID51 | / | 0.441 | |
4o76 | 1M3 | Bromodomain-containing protein 4 | / | 0.441 | |
4ucn | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.441 | |
5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
5cwa | 0GA | Anthranilate synthase component 1 | 4.1.3.27 | 0.441 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.440 | |
1onp | FOM | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.440 | |
1ykd | CMP | Adenylate cyclase | / | 0.440 | |
2ay8 | 4TB | Aromatic-amino-acid aminotransferase | 2.6.1.57 | 0.440 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.440 | |
2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.440 | |
2qu6 | 857 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
2rkf | AB1 | Pol protein | / | 0.440 | |
2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.440 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
3ict | FAD | Coenzyme A disulfide reductase | / | 0.440 | |
3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.440 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
3sru | Q26 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
4c2z | MYA | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.440 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.440 | |
4dti | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
4e37 | NDP | Catalase | 1.11.1.6 | 0.440 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.440 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.440 | |
4ly9 | 1YY | Glucokinase regulatory protein | / | 0.440 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.440 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |